LinkedIn has verified 55 million users to combat AI misinformation

Nucor (NYSE: NUE) stands out as a leading North American steelmaker and a Dividend King, currently perceived unfavorably by Wall Street, which may present a buying opportunity for long-term investors. The company's use of electric arc mini-mills allows for flexible production adjustments based on demand, supporting profit margins throughout industry cycles. Want More Context? 🔎

AT&T (NYSE: T) saw its stock rise by 1.6% during Monday's trading, outperforming the S&P 500 and Nasdaq Composite, which gained 0.1% and 0.3%, respectively. The increase was partly fueled by positive market sentiment following Verizon's bullish second-quarter earnings report, which investors interpreted as a good sign for the telecommunications sector. Want More Context? 🔎

Major players in the electric vehicle market, Nio (NYSE: NIO) and Rivian (NASDAQ: RIVN), are pursuing distinct strategies to achieve electric dominance, reshaping the perception of success in the EV sector. This exploration offers insights for investors looking to understand the future landscape of electric mobility. Want More Context? 🔎

Oil prices, particularly West Texas Intermediate, have fluctuated between $60 and $80 this year, impacting the cash flows of oil producers and their ability to maintain dividends. Despite this volatility, high-yield stocks like Enterprise Products Partners (NYSE: EPD), Chevron (NYSE: CVX), and Enbridge (NYSE: ENB) are noted for their resilience and reliability as income investments. Want More Context? 🔎

Investors often focus on the technology sector for high returns, but other areas like retail can also yield significant gains. Since mid-July 1995, one retail stock has achieved a remarkable total return of over 16,000%, demonstrating the benefits of patience and compounding, making a $1,000 investment worth $163,000 today. Explain It To Me Like I'm 5: Some smart investors found a really good store to put their money in a long time ago, and now...

Investors looking for potential "monster stocks" should consider the biotech sector, which offers promising early-stage companies. Three Motley Fool contributors highlight CRISPR Therapeutics (NASDAQ: CRSP), Summit Therapeutics (NASDAQ: SMMT), and Viking Therapeutics (NASDAQ: VKTX) as stocks with significant growth potential. Explain It To Me Like I'm 5: Some smart people think there are special companies that make medicine, called biotech stocks, and they believe that CRISPR Therapeutics, Summit Therapeutics, and Viking Therapeutics could become really...